Hjem › Pankreaskreft › California › San Francisco
Kliniske studier for Pankreaskreft i San Francisco, CA
20 studier for Pankreaskreft søker deltakere på steder i og rundt San Francisco (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
RekruttererFase 1/2
- Research Site, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
- Kaiser Permanente-San Francisco, San Francisco
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekruttererFase 3
- University of California, San Francisco, San Francisco
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekruttererFase 3
- Investigative Site US034, San Francisco
UCSF PANC Cyst Registry
RekruttererObservasjonsstudie
- University of California, San Francisco, San Francisco
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
RekruttererObservasjonsstudie
- University of California, San Francisco, San Francisco
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
RekruttererFase 2
- Local Institution - 0096, San Francisco
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekruttererObservasjonsstudie
- UCSF Medical Center-Mount Zion, San Francisco
- UCSF Medical Center-Parnassus, San Francisco
- UCSF Medical Center-Mission Bay, San Francisco
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekruttererFase 3
- California Pacific Medical Center-Pacific Campus, San Francisco
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
RekruttererFase 1
- UCSF, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- University of California San Francisco Cancer Center, San Francisco
Pancreatic Cancer Early Detection Consortium
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- University of California, San Francisco (UCSF), San Francisco
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RekruttererFase 3
- California Pacific Medical Center-Pacific Campus, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekrutterer
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A Study of MGC028 in Participants With Advanced Solid Tumors
RekruttererFase 1
- UCSF - Helen Diller Family Cancer Center, San Francisco
Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
RekruttererTidlig fase 1
- Stanford University, San Francisco
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekruttererFase 1/2
- University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekruttererFase 2
- Ohio State University-Telemedicine, San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RekruttererFase 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, San Francisco
Pankreaskreft-studier i andre byer
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Arlington, VA33 studier
- Baltimore, MD31 studier
- San Antonio, TX31 studier
- Philadelphia, PA26 studier
- Tampa, FL26 studier
- Durham, NC24 studier
Andre studier i San Francisco
- Prostatakreft45 studier
- Brystkreft43 studier
- Ikke-småcellet lungekreft36 studier
- Kreft (alle typer)35 studier
- Hjertesvikt29 studier
- Metastatisk kreft28 studier
- Lungekreft22 studier
- Melanom22 studier
- Eggstokkreft19 studier
- Kolorektal kreft18 studier
- Kardiovaskulær sykdom18 studier
- Glioblastom17 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.